Editorial: Microbiome: the modulator of human health

Editorial: Microbiome: the modulator of human health

Saved in:

Bibliographic Details
Main Authors:	Ji Youn Yoo, Moumita Dutta
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Pharmacology
Subjects:	gut microbiome bile acid Streptococcus melatonin ulcerative colitis berberine
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1625412/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Diets for inflammatory bowel disease: impact on microbiome and immunomodulatory microbial metabolites
by: Hebe Mendez, et al.
Published: (2025-04-01)

Gut microbiomes and treatment-resistant ulcerative colitis: a case-control study using qPCR
by: Amjad Ahmadi, et al.
Published: (2025-04-01)

Design and Activity Evaluation of Berberine-Loaded Dual pH and Enzyme-Sensitive Colon-Targeting Microparticles
by: Jingqi Sun, et al.
Published: (2025-06-01)

Microbiome-derived bile acids as endogenous regenerative mediators in liver repair
by: Surya Nath Pandey, et al.
Published: (2025-12-01)

Global research trends on the interaction between gut microbiome and bile acids: a bibliometric and visualized analysis
by: Fangli Luo, et al.
Published: (2025-07-01)

Integration of Pseudotargeted Metabolomics and Microbiomics Reveals That Hugan Tablets Ameliorate NASH with Liver Fibrosis in Mice by Modulating Bile Acid Metabolism via the Gut Microbiome
by: Wenran Dong, et al.
Published: (2025-06-01)

Gut virome profile in new onset treatment naïve Saudi children with ulcerative colitis
by: Mohammad El Mouzan, et al.
Published: (2025-07-01)

Gentiopicroside improves DSS-induced ulcerative colitis and secondary liver injury in mice by enhancing the intestinal barrier and regulating the gut microbiome
by: Liu Cao, et al.
Published: (2025-07-01)

Anemoside B4 alleviates ulcerative colitis by attenuating intestinal oxidative stress and NLRP3 inflammasome via activating aryl hydrocarbon receptor through remodeling the gut microbiome and metabolites
by: Hao Wu, et al.
Published: (2025-09-01)

In silico metabolic modelling links microbiome-derived metabolites to risk factors of Alzheimer’s disease
by: Tim Hensen, et al.
Published: (2025-12-01)

Effect of melatonin on gut microbiome and metabolomics in diabetic cognitive impairment
by: Ming Gao, et al.
Published: (2024-11-01)

Influence of gut microbiome composition on effect variations of anti-cholesterol treatment among individual mice
by: Hyemin Oh, et al.
Published: (2024-09-01)

Novel microbially transformed bile acids: Biosynthesis, structure, and function
by: Qi Zhao, et al.
Published: (2025-06-01)

Weissella cibaria suppresses colitis-associated colorectal cancer by modulating the gut microbiota-bile acid-FXR axis
by: Qiuyao Hao, et al.
Published: (2025-07-01)

Bile acids enhance fat metabolism and skeletal muscle development in Zhijiang duck by modulating gut microbiota
by: Liang Chen, et al.
Published: (2025-08-01)

Bile acid 7α-dehydroxylating bacteria accelerate injury-induced mucosal healing in the colon
by: Antoine Jalil, et al.
Published: (2025-03-01)

Perspectives on Berberine and the Regulation of Gut Microbiota: As an Anti-Inflammatory Agent
by: Quintero Vargas Jael Teresa de Jesús, et al.
Published: (2025-01-01)

Impact of Vitamins, Antibiotics, Probiotics, and History of COVID-19 on the Gut Microbiome in Ulcerative Colitis Patients: A Cross-Sectional Study
by: Zane Straume, et al.
Published: (2025-02-01)

Gut microbial metabolism of bile acids modifies the effect of Mediterranean diet interventions on cardiometabolic risk in a randomized controlled trial
by: Peipei Gao, et al.
Published: (2024-12-01)

Comprehensive plasma metabolomics analysis of berberine treatment in ulcerative colitis rats by LC-MS/MS
by: Baodong Feng, et al.
Published: (2024-12-01)

Prediabetes and type 2 diabetes but not obesity are associated with alterations in bile acid related gut microbe-microbe and gut microbe-host community metabolism
by: Kristina Schlicht, et al.
Published: (2025-12-01)

The role of gut microbiota in disease management: Ayurvedic perspectives on metabolic diseases and health
by: Bhawana Jangra, et al.
Published: (2025-02-01)

Increased reflux secondary bile acids are associated with changes to the microbiome and transcriptome in Barrett’s esophagus
by: Ceylan Tanes, et al.
Published: (2025-12-01)

Electroacupuncture Modulates Microbial Phenylalanine Metabolism and Enhances the Intestinal Barrier Function to Alleviate Colitis in Mice
by: Zhu L, et al.
Published: (2024-10-01)

HLF and PPARα axis regulates metabolic‐associated fatty liver disease through extracellular vesicles derived from the intestinal microbiota
by: Xingzhen Yang, et al.
Published: (2025-04-01)

Bacterial dysbiosis in newly diagnosed treatment naïve pediatric ulcerative colitis in Saudi Arabia
by: Mohammad El Mouzan, et al.
Published: (2025-01-01)

Anthocyanin-Rich Extract Mitigates the Contribution of the Pathobiont Genus <i>Haemophilus</i> in Mild-to-Moderate Ulcerative Colitis Patients
by: Yannik Zobrist, et al.
Published: (2024-11-01)

THE FUNCTIONAL STATUS OF THE BILIARY SYSTEM AND LITHOGENECITY OF BILE IN PATIENTS WITH THE INFLAMMATORY BOWEL DISEASES
by: A. A. Markidonova, et al.
Published: (2013-12-01)

Evaluation of microbiome composition combined with serum untargeted metabolomic profiling in newly diagnosed children with inflammatory bowel disease
by: Katarzyna Zdanowicz, et al.
Published: (2024-07-01)

Protective Effects of Zein/Ferulic Acid (FA)–Pectin (PEC)/Chitosan (CS) Nanocomplexes on DSS-Induced Ulcerative Colitis in Mice
by: Yifei Guo, et al.
Published: (2025-07-01)

Didymin Ameliorates Dextran Sulfate Sodium (DSS)-Induced Ulcerative Colitis by Regulating Gut Microbiota and Amino Acid Metabolism in Mice
by: Zhongxing Chu, et al.
Published: (2024-10-01)

Berberine alleviates enterotoxigenic Escherichia coli-induced intestinal mucosal barrier function damage in a piglet model by modulation of the intestinal microbiome
by: Min Du, et al.
Published: (2025-01-01)

Exploring the therapeutic effects of Zingiberis Rhizoma Preparatum (Pao-Jiang) against DSS-induced ulcerative colitis in mice by metabolomics-guided analysis
by: Jianliang Geng, et al.
Published: (2023-12-01)

β-ionone prevents dextran sulfate sodium-induced ulcerative colitis and modulates gut microbiota in mice
by: Jingjing Fang, et al.
Published: (2024-10-01)

Exploring the etiology of colitis: insights from gut microbiota research
by: Guanru Qian, et al.
Published: (2025-12-01)

Characterization of the salivary microbiome of adults with inflammatory bowel disease
by: Vanessa DeClercq, et al.
Published: (2025-12-01)

Advances in research on the role of gut microbiota in the pathogenesis and precision management of gallstone disease
by: Ludong Tan, et al.
Published: (2025-06-01)

Unraveling the Role of the Human Gut Microbiome in Health and Diseases
by: Mohamad Khalil, et al.
Published: (2024-11-01)

Zhili decoction ameliorates ulcerative colitis by modulating gut microbiota and related metabolite, and inhibiting the TLR4/NF-κB/NLRP3 pathway
by: Tianying Tan, et al.
Published: (2024-12-01)

Bifidobacterium longum subsp. infantis CCFM1426 enhances the anti-colitic effect of vitamin A via retinoic acid restoration and gut microbiota modulation in ulcerative colitis mice
by: Xihua Yu, et al.
Published: (2025-07-01)